These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16341033)

  • 21. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.
    Arber DA; Chang KL; Lyda MH; Bedell V; Spielberger R; Slovak ML
    Hum Pathol; 2003 Aug; 34(8):809-13. PubMed ID: 14506644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
    Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
    Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
    Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
    PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene,
    Torkildsen S; Brunetti M; Gorunova L; Spetalen S; Beiske K; Heim S; Panagopoulos I
    Anticancer Res; 2017 Feb; 37(2):693-698. PubMed ID: 28179318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma.
    Sameeta F; Fang H; Wang W; Tang Z; Wang SA; Toruner GA; Parisi X; Khoury JD; Issa G; Garcia-Manero G; Medeiros LJ; Tang G; Loghavi S
    Am J Hematol; 2024 Sep; 99(9):1827-1829. PubMed ID: 38440855
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of an NPM1/MLF1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia.
    Aypar U; Knudson RA; Pearce KE; Wiktor AE; Ketterling RP
    J Mol Diagn; 2014 Sep; 16(5):527-532. PubMed ID: 25027285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocation (3;5)(q21;q34) in erythroleukemia: a molecular and in situ hybridization study.
    Kwong YL
    Cancer Genet Cytogenet; 1998 May; 103(1):15-9. PubMed ID: 9595039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation.
    Crowley JA; Wang Y; Rapoport AP; Ning Y
    Leukemia; 2005 Dec; 19(12):2344-5. PubMed ID: 16193081
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
    Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
    Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).
    Sevilla J; Fernández-Plaza S; Lassaletta A; González-Vicent M; Contra T; Madero L
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):839-40. PubMed ID: 18090933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
    Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
    Falini B; Nicoletti I; Martelli MF; Mecucci C
    Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
    Schmidt HH
    Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
    [No Abstract]   [Full Text] [Related]  

  • 37. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance.
    Alcalay M; Tiacci E; Bergomas R; Bigerna B; Venturini E; Minardi SP; Meani N; Diverio D; Bernard L; Tizzoni L; Volorio S; Luzi L; Colombo E; Lo Coco F; Mecucci C; Falini B; Pelicci PG
    Blood; 2005 Aug; 106(3):899-902. PubMed ID: 15831697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML/RARA rearrangement associated with a t(15;19;17) in a case of acute myeloid leukemia with abundant myelocytes with salmon-pink cytoplasm.
    Kim IS; Kim HJ; Choung HS; Jung CW; Kim JW; Kim SH
    Cancer Genet Cytogenet; 2006 Aug; 169(1):81-2. PubMed ID: 16875944
    [No Abstract]   [Full Text] [Related]  

  • 40. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.